Dr. Levey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1841 Clifton Rd
Atlanta, GA 30322Phone+1 404-778-3444
Summary
- Dr. Allan Levey is a neurologist and neuroscientist in Atlanta, GA and is a faculty member at Emory University. He received his medical degree and PhD from University of Chicago Pritzker School of Medicine and has been in practice 33 years. He specializes in cognitive neurology.
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
- Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1984 - 1985
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984
Certifications & Licensure
- GA State Medical License 1991 - 2025
- NC State Medical License 2020 - 2022
- MD State Medical License 1989 - 1992
- IL State Medical License 1985 - 1987
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Effects of Atomoxetine in Mild Cognitive Impairment Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 132 citationsTransethnic genome-wide scan identifies novel Alzheimer's disease lociGyungah Jun, Jaeyoon Chung, Jesse Mez, Robert Barber, Gary W. Beecham
Alzheimer's & Dementia. 2017-07-01 - 246 citationsLoss-of-function variants in ABCA7 confer risk of Alzheimer's diseaseStacy Steinberg, Hreinn Stefansson, Thorlakur Jonsson, Hrefna Johannsdottir, Andres Ingason
Nature Genetics. 2015-05-01 - 194 citationsA novel Alzheimer disease locus located near the gene encoding tau proteinGyungah Jun, Carla A. Ibrahim-Verbaas, Maria Vronskaya, J-C Lambert, Jaeyoon Chung
Molecular Psychiatry. 2016-01-01
Journal Articles
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentIhab Hajjar, Allan Levey, JAMA Network Open
Authored Content
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
Press Mentions
- Emory Receives $22 Million Grant to Research ‘Type 3 Diabetes’October 4th, 2024
- GA Health System to Deploy AI-Based Alzheimer’s Detection ToolFebruary 23rd, 2023
- Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other DementiasFebruary 17th, 2023
- Join now to see all
Grant Support
- Emory Alzheimer'S Disease CenterNational Institute On Aging2010–2012
- Lr11, A Novel Receptor In Mild Cognitive ImpairmentNational Institute On Aging2008–2012
- Emory Neuroscience Ninds Core FacilitiesNational Institute Of Neurological Disorders And Stroke2008–2012
- Administrative CoreNational Institute On Aging2005–2012
- Training In Translational Research In NeurologyNational Institute Of Neurological Disorders And Stroke2004–2011
- The Emory Alzheimer'S Disease CenterNational Institute On Aging2005–2009
- Crossed Genetic Risk Of Alzheimer And Parkinson DiseaseNational Institute On Aging2005–2009
- Muscarinic Receptors In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2005–2009
- Medical Scientists Training ProgramNational Institute Of General Medical Sciences2002–2006
- Muscarinic Receptor Proteins In Alzheimers DiseaseNational Institute Of Neurological Disorders And Stroke1994–2003
- Genetic And Pathological Study Of Sporadic PDNational Institute Of Environmental Health Sciences2002
- Monamine Transporters In ParkinsonismNational Institute Of Neurological Disorders And Stroke1998–2001
- Medical Scientist Training ProgramNational Institute Of General Medical Sciences1997–2001
- Emory Alzheimers Disease CenterNational Institute On Aging1999–2000
- Core--ClinicalNational Institute On Aging1996–2000
- Basal Ganglia--Molecular Pharmacology And AnatomyNational Institute Of Neurological Disorders And Stroke1996–1998
- Minority Biomedical Research SupportNational Institute Of General Medical Sciences1994–1995
- Muscarinic Receptor Proteins In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke1991–1993
- Localization Of Muscarinic Receptor Proteins M1-M5National Institute Of Neurological Disorders And Stroke1991
- Localization Of Muscarinic Receptor Proteins M1-M5National Institute Of Neurological Disorders And Stroke1989–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: